ABILIFY- aripiprazole tablet
ABILIFY- aripiprazole solution
ABILIFY- aripiprazole tablet, orally disintegrating
ABILIFY- arip США - англійська - NLM (National Library of Medicine)

abilify- aripiprazole tablet abilify- aripiprazole solution abilify- aripiprazole tablet, orally disintegrating abilify- arip

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

Dioralyte Relief oral powder sachets raspberry Велика Британія - англійська - MHRA (Medicines & Healthcare Products Regulatory Agency)

dioralyte relief oral powder sachets raspberry

dendron brands ltd - sodium chloride; potassium chloride; sodium citrate; rice powder pre-cooked - powder for oral solution - 350mg ; 300mg ; 580mg ; 6gram

KALETRA ORAL SOLUTION Ізраїль - англійська - Ministry of Health

kaletra oral solution

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - solution (oral) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

KALETRA ORAL SOLUTION Ізраїль - англійська - Ministry of Health

kaletra oral solution

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - solution (oral) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

OLANZAPINE - olanzapine tablet, orally disintegrating США - англійська - NLM (National Library of Medicine)

olanzapine - olanzapine tablet, orally disintegrating

ajanta pharma limited - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - olanzapine 5 mg -     oral olanzapine is indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13-17), efficacy was established in one 6-week trial [see clinical studies (14.1)] .     when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia . clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see warnings and precautions (5.5)] .     monotherapy — oral olanzapine is indicated for the acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i disorder. efficacy was established in three clinical trials in adult patients with man

Aripiprazole Oral Solution 1mg/ml Мальта - англійська - Medicines Authority

aripiprazole oral solution 1mg/ml

liqmeds limited - aripiprazole - oral drops, solution - aripiprazole 1 milligram(s) - psycholeptics

OLANZAPINE- olanzapine tablet, orally disintegrating США - англійська - NLM (National Library of Medicine)

olanzapine- olanzapine tablet, orally disintegrating

a-s medication solutions - olanzapine (unii: n7u69t4szr) (olanzapine - unii:n7u69t4szr) - oral olanzapine is indicated for the treatment of schizophrenia. efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. in adolescent patients with schizophrenia (ages 13 to 17), efficacy was established in one 6-week trial [ see clinical studies (14.1)].    when deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. clinicians should consider the potential long-term risks  when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents [see  warnings and precautions (5.5 )].  oral olanzapine is indicated for acute treatment of manic or mixed episodes associated with bipolar i disorder and maintenance treatment of bipolar i disorder. efficacy was established in three clinical trials in adult patients with manic or mixed episodes of

Aripiprazole 1mg/ml oral solution Ірландія - англійська - HPRA (Health Products Regulatory Authority)

aripiprazole 1mg/ml oral solution

pinewood laboratories ltd, - aripiprazole - oral solution - 1 milligram(s)/millilitre - other antipsychotics; aripiprazole

Denzapine 50 mg/ml Oral Suspension Ірландія - англійська - HPRA (Health Products Regulatory Authority)

denzapine 50 mg/ml oral suspension

clonmel healthcare ltd - clozapine - oral suspension - 50 milligram(s)/millilitre - diazepines, oxazepines, thiazepines and oxepines; clozapine